Search at Vanderbilt-Ingram Cancer Center

1284 results found

Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis

Relevance: 1

Identifying Effective and Cost-Conscious Maintenance Daratumumab Dosing

Relevance: 1

An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Relevance: 1

Nonconforming Lisocabtagene Maraleucel Expanded Access Protocol

Relevance: 1

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

Relevance: 1

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

Relevance: 1

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Relevance: 1

Nemtabrutinib With CAR T Therapy in Relapsed/Refractory Mantle Cell Lymphoma

Relevance: 1

Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)

Relevance: 1

Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

Relevance: 1